Breast cancer · JAMA Netw Open · 2025
Summary: on hormone therapy, overweight women’s breast-cancer risk is 1.40×. That’s obese women’s figure; theirs: 2.18×.
Times as likely to get breast cancer on hormone therapy, with likely ranges
The paper says
Women past menopause on estrogen-plus-progestin therapy are more likely than non-users to get two kinds of breast cancer (call them A and B). The summary: healthy weight, 2.51 times as likely (A) and 1.95 (B); overweight, 1.40; obese, 1.68, kind not named.
Its own data show
The paper’s results and supplement list each kind separately. The summary’s overweight figure, 1.40 (range 1.02 to 1.92, where the true value likely lies), is exactly obese women’s figure for A; its obese 1.68 is obese women’s for B. Overweight women’s own figures, 2.18 (A) and 1.83 (B), appear nowhere in the summary.
“1.40 times as likely” means 40% more likely; 2.18 means 118% more. Most readers see just the summary. There, overweight women see about a third (40 of 118) of their extra risk of kind A, and risk seems to rise from overweight to obese. In the results it falls with weight for both kinds (A: 2.51, 2.18, 1.40).